Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa study of inhaled TRN-157 nebulizer solution in patients with chronic obstructive pulmonary disease
CTR20242959Phase 2Completed
- Sponsor
- Shandong Lukang Pharmaceutical Co., Ltd.
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of trn-157 in chronic obstructive pulmonary disease (COPD), sponsored by Shandong Lukang Pharmaceutical Co., Ltd.. Started Aug 2024; status: completed.
02
Drugs
trn-157
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on CTR20242959.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20242959.